IP Library Granted Patent US 9,655,669
Granted Patent B2
US 9,655,669 · App. 14/269,784 · Granted May 23, 2017

Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,655,669
App. No.
14/269,784
Granted
May 23, 2017
Kind
B2
Abstract

Tumors can be treated with an alternating electric field. The size of cells in the tumor is determined prior to the start of treatment by, for example, biopsy or by inverse electric impedance tomography. A treatment frequency is chosen based on the determined cell size. The cell size can be determined during the course of treatment and the treatment frequency is adjusted to reflect changes in the cell size. A suitable apparatus for this purpose includes a device for measuring the tumor impedance, an AC signal generator with a controllable output frequency, a processor for estimating the size of tumor cells and setting the frequency of the AC signal generator based thereon, and at least one pair of electrodes operatively connected to the AC signal generator such that an alternating electric field is applied to the tumor.

Claims (43)

1. A method for adaptively treating a tumor with an alternating electric field, the method comprising the steps of:

determining a first size of cells in the tumor;

selecting a first frequency based on the determined first size;

applying an alternating electric field to the tumor at the first frequency to treat the tumor;

waiting a period of time and subsequently determining a second size of cells in the tumor;

selecting a second frequency based on the determined second size; and

applying an alternating electric field to the tumor at the second frequency to treat the tumor,

wherein the first frequency and the second frequency are selected based on an average cell size.

2. The method of claim 1 , wherein

the first size and the second size are determined based on a tumor biopsy.

3. The method of claim 1 , wherein

the first size and the second size are determined based on a measured impedance of the tumor.

4. The method of claim 3 , wherein

the determinations of the first size and the second size are made based on a Cole-Cole plot.

5. The method of claim 3 , further comprising the steps of:

imaging the tumor with CT, MRI, or PET to locate portions of the tumor not having blood or cyst fluid; and

determining the first size and the second size based on a measure impedance of the located portions.

6. The method of claim 3 , wherein

the tumor is a glioma tumor or a melanoma tumor.

7. The method of claim 1 , wherein

the period of time is at least one week.

8. The method of claim 1 , wherein

the period of time is at least one month.

9. The method of claim 1 , wherein

the first frequency and the second frequency are selected based on a spectrum of cell sizes.

10. The method of claim 1 wherein

the period of time is chosen based on the type of tumor.

11. The method of claim 1 wherein

the period of time is chosen based on the history of the tumor.

12. The method of claim 1 , wherein

the first size and the second size are determined based on a database look-up table.

13. A method for adaptively providing a medical treatment to a patient, the method comprising the steps of:

applying an alternating electric field to a group of patient cells;

determining a first impedance of the group of patient cells based on a measured current while the alternating electric field is applied;

estimating a first size of cells in the group of patient cells based on the first impedance;

applying a second alternating electric field to the group of patient cells;

determining a second impedance of the group of patient cells based on a measured current while the second alternating electric field is applied;

estimating a second size of cells in the group of patient cells based on the second impedance;

selecting a treatment parameter based on an average of the estimated size of cells; and

applying a treatment to the patient in accordance with the selected treatment parameter.

14. The method of claim 13 , further comprising the steps of:

waiting for a period of time between the applying the alternating electric field and the applying the second alternating electric field.

15. The method of claim 13 , wherein the medical treatment is a surgery or therapy.

Assignments (15)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2014
From: PALTI, YORAM; DISHON, MATAN
To: NOVOCURE LIMITED
Reel/Frame 034574/0048 →